BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8997525)

  • 21. Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells.
    Ricaud S; Vernus B; Duclos M; Bernardi H; Ritvos O; Carnac G; Bonnieu A
    Oncogene; 2003 Nov; 22(51):8221-32. PubMed ID: 14614446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J; Zhe X
    Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of different methods of pEGFP-actin plasmid transfection to the endothelium].
    Luo Q; Qi J; Chen J; Luo X; Yang Z
    Zhonghua Shao Shang Za Zhi; 2002 Jun; 18(3):170-2. PubMed ID: 12460515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
    Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
    Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells.
    Marchal JA; Prados J; Melguizo C; Fernández JE; Vélez C; Alvarez L; Aránega A
    J Lab Clin Med; 1997 Jul; 130(1):42-50. PubMed ID: 9242365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
    Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfection of rhabdomyosarcoma cells with connexin43 induces myogenic differentiation.
    Proulx AA; Lin ZX; Naus CC
    Cell Growth Differ; 1997 May; 8(5):533-40. PubMed ID: 9149904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
    Sirri V; Leibovitch MP; Leibovitch SA
    Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing electroporation parameters for a variety of human hematopoietic cell lines.
    McNally MA; Lebkowski JS; Okarma TB; Lerch LB
    Biotechniques; 1988 Oct; 6(9):882-6. PubMed ID: 3273199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells.
    Shang YC; Wang SH; Xiong F; Zhao CP; Peng FN; Feng SW; Li MS; Li Y; Zhang C
    Acta Pharmacol Sin; 2007 Nov; 28(11):1761-74. PubMed ID: 17959027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of electroporation by flow cytometry.
    Michie J; Janssens D; Cilliers J; Smit BJ; Böhm L
    Cytometry; 2000 Oct; 41(2):96-101. PubMed ID: 11002264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel electroporation method using a capillary and wire-type electrode.
    Kim JA; Cho K; Shin MS; Lee WG; Jung N; Chung C; Chang JK
    Biosens Bioelectron; 2008 Apr; 23(9):1353-60. PubMed ID: 18242073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma.
    Kikuchi K; Tsuchiya K; Otabe O; Gotoh T; Tamura S; Katsumi Y; Yagyu S; Tsubai-Shimizu S; Miyachi M; Iehara T; Hosoi H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):568-74. PubMed ID: 18022385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program.
    Seidl K; Erck C; Buchberger A
    J Cell Physiol; 1998 Jul; 176(1):10-21. PubMed ID: 9618140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
    Mercer SE; Ewton DZ; Shah S; Naqvi A; Friedman E
    Cancer Res; 2006 May; 66(10):5143-50. PubMed ID: 16707437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
    Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
    Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].
    Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):543-7. PubMed ID: 16468332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroporation of cynomolgus monkey embryonic stem cells.
    Furuya M; Yasuchika K; Mizutani K; Yoshimura Y; Nakatsuji N; Suemori H
    Genesis; 2003 Dec; 37(4):180-7. PubMed ID: 14666511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation potential of intestinal mesenchyme and its interaction with epithelial cells: a study using beta-galactosidase-expressing fibroblast lines.
    Subramanian V; Sneddon SF; Martin L; Evans GS
    Cell Biol Int; 2001; 25(8):741-51. PubMed ID: 11482898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
    Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.